Mycobacterial laboratory assays taken at study clinics, stratified by assay used, sex and age of person tested, with proportion and rates positive for <i>M</i>. <i>tuberculosis</i> and presence of rifampicin resistance; by arm and by period.

Mycobacterial laboratory assays taken at study clinics, stratified by assay used, sex and age of person tested, with proportion and rates positive for <i>M</i>. <i>tuberculosis</i> and presence of rifampicin resistance; by arm and by period.

<p>Mycobacterial laboratory assays taken at study clinics, stratified by assay used, sex and age of person tested, with proportion and rates positive for <i>M</i>. <i>tuberculosis</i> and presence of rifampicin resistance; by arm and by period.</p>

Saved in:

Bibliographic Details
Main Author:	Neil A. Martinson (8587299) (author)
Other Authors:	Bareng A. S. Nonyane (8661561) (author), Leisha P. Genade (15810802) (author), Rebecca H. Berhanu (15338648) (author), Pren Naidoo (606701) (author), Zameer Brey (15810805) (author), Anthony Kinghorn (5549672) (author), Sipho Nyathi (15810808) (author), Katherine Young (526710) (author), Harry Hausler (3214485) (author), Lucy Connell (15810811) (author), Keeren Lutchminarain (15810814) (author), Khine Swe Swe-Han (6596060) (author), Helena Vreede (15810817) (author), Mohamed Said (3588056) (author), Nina von Knorring (334027) (author), Lawrence H. Moulton (7871810) (author), Limakatso Lebina (554886) (author)
Published:	2023
Subjects:	Medicine Neuroscience Biotechnology Cancer Science Policy Infectious Diseases Virology Computational Biology world health organization week later due targeted universal testing recent close contact premature stop due differences analyses showed analyzed data abstracted march 2020 due coronavirus disease 2019 clinics restricting access incidence rate ratio control clinics decreased primary care clinics risk groups diagnosed interaction irr 1 march 2019 control clinics two clinics intervention clinics extreme risk 3 groups xlink "> versus 6 sputum test south africa significant difference reported symptoms relative increase prior year prior episode prespecified difference prematurely stopped power estimates permanently stopped novel intervention national lockdown large urban identify millions exacerbate morbidity direct comparison delayed diagnosis current standard could assist ci 16 ci 15 ci 1 attendees living arm comparisons 6 months 4901 </ 46 ). 001 ).
Tags:	Add Tag No Tags, Be the first to tag this record!